Email not displaying correctly? View online version
Innovations of Today
Curalta Foot + Ankle brings a wide array of talented practitioners together, but our commitment to excellence and the benefits of shared expertise are only one part of our story. Under the leadership of Dr. Vincent Giacalone, our Director of Research and Clinical Trials, we also make clinical trials and pioneering treatments a top priority. Advancing medical science is at the heart of delivering exceptional patient care, and we are dedicated to bringing innovative solutions to the forefront. Explore how our cutting-edge clinical trials are redefining healthcare standards and shaping the future of patient care!
Current Trials
Diabetic Foot Ulcer - Grade 1 or 2, Non-Infected
- Concurrent optical and magnetic stimulation (COMS) for treatment of refractory diabetic foot ulcer; a prospective randomized, sham-controlled, double-blinded, pivotal clinical trial.
- A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Diabetic Foot Ulcers Treated with Standard Care with or without BR-AC.
Diabetic Peripheral Neuropathy
A Post-Market Observational Multi-Center Study to Evaluate the Effectiveness of Repeated QUTENZA Use in Adults with Painful Diabetic Peripheral Neuropathy of the Feet.
Peripheral Arterial Disease
The use of Hemodynamic Occlusive Vascular Response (HOVRTM) technology to assess the impact of peripheral artery disease (PAD) on tissue perfusion and oxygenation in the foot.
Plantar Fibroma Study
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis.
Venous Leg Ulcer Study
A Phase 3 Randomized, Parallel Group, Double-Blind, study to Evaluate the Efficacy, Tolerability, andSafety of TR987® 0.1% gel versus Standard of Care in the treatment of Chronic Venous Insufficiency Leg Ulcers (VLU). This will be starting in March of 2025
Ready to join our growing Curalta Family?
Follow us on social media:
